Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.AuthorsBadar, Talha; Handisides, Damian R.; Benito, Juliana M.; Richie, Mary Ann; Borthakur, Gautam; Jabbour, Elias; Harutyunyan, Karine; Konoplev, Sergej; Faderl, Stefan; Kroll, Stew; Andreeff, Michael; Pearce, Tillman; Kantarjian, Hagop M.; Cortes, Jorge E.; Thomas, Deborah A.; Konopleva, MarinaPublicationAmerican Journal of Hematology, 2016, Vol 91, Issue 8, p800ISSN0361-8609Publication typeArticleDOI10.1002/ajh.24415